Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Day One Biopharmaceuticals (DAWN)
NASDAQ:DAWN
RESEARCH TOOLSreports
Day One Biopharmaceuticals (DAWN) Ownership - Who Owns Day One Biopharmaceuticals?
197 Followers
Day One Biopharmaceuticals (DAWN) Ownership Overview
56.10% Insiders
20.47% Mutual Funds
11.33% Other Institutional Investors
12.10% Public Companies and Individual Investors
The ownership structure of Day One Biopharmaceuticals (DAWN) stock is a mix of institutional, retail and individual investors. Approximately 31.80% of the company’s stock is owned by Institutional Investors, 56.10% is owned by Insiders and 12.10% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 21, 2024 | Saira Ramasastry Director | xxxxxxxxxxxxx | $131800 |
| Oct 20, 2023 | Ai Day1 Llc >10% Owner | xxxxxxxxxxxxx | $14970196 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $9614 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $11878061 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $20758536 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $29162954 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,809,852 | Institution | 8.94% | 116,991,583 | |
| 4,407,682 | Institution | 5.04% | 66,027,076 | |
| 4,092,371 | Institution | 4.68% | 61,303,718 | |
| 2,648,825 | Institution | 3.03% | 39,679,399 | |
| 2,558,563 | Institution | 2.93% | 38,327,274 | |
| 2,039,003 | Institution | 2.33% | 30,544,265 | |
| 2,018,849 | Institution | 2.31% | 30,242,358 | |
| 1,765,312 | Institution | 2.02% | 26,444,374 | |
| 1,613,002 | Institution | 1.85% | 24,162,770 | |
| 1,430,839 | Institution | 1.64% | 21,433,968 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,092,371 | Institution | 4.68% | 61,303,718 | |
| 2,039,003 | Institution | 2.33% | 30,544,265 | |
| 2,018,849 | Institution | 2.31% | 30,242,358 | |
| 1,430,839 | Institution | 1.64% | 21,433,968 | |
| 1,399,110 | Institution | 1.60% | 20,958,668 | |
| 1,027,608 | Institution | 1.18% | 15,393,568 | |
| 661,859 | Institution | 0.76% | 9,914,648 | |
| 607,633 | Institution | 0.70% | 9,102,342 | |
| 521,754 | Institution | 0.60% | 7,815,875 | |
| 461,933 | Institution | 0.53% | 6,919,756 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,884,570 | Institution | 2.16% | 25,969,375 | |
| 1,538,025 | Institution | 1.76% | 23,039,615 | |
| 1,394,410 | Institution | 1.60% | 20,888,262 | |
| 795,241 | Institution | 0.91% | 10,958,421 | |
| 768,878 | Institution | 0.88% | 10,595,139 | |
| 517,296 | Institution | 0.59% | 7,128,339 | |
| 448,198 | Institution | 0.51% | 6,714,006 | |
| 418,610 | Institution | 0.48% | 6,270,778 | |
| 261,865 | Institution | 0.30% | 3,922,738 | |
| 193,235 | Institution | 0.22% | 2,662,778 |
FAQ
Who Owns Day One Biopharmaceuticals (DAWN)?
According to the latest TipRanks data, approximately 11.33% of the company's stock is held by institutional investors, 56.10% is held by insiders, and 12.10% is held by retail investors.
What percentage of Day One Biopharmaceuticals (DAWN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 11.33% of Day One Biopharmaceuticals (DAWN) stock is held by institutional investors.
What percentage of Day One Biopharmaceuticals (DAWN) stock is held by retail investors?
According to the latest TipRanks data, approximately 12.10% of Day One Biopharmaceuticals (DAWN) stock is held by retail investors.
Who owns the most shares of Day One Biopharmaceuticals (DAWN)?
Peter Kolchinsky owns the most shares of Day One Biopharmaceuticals (DAWN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.